Resources Contact Us Home
Modified factor VIII

Image Number 4 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
High voltage circuit for electrical stimulation
Zoom lens
Policy based cryptographic application programming interface in secure memory
Systems and methods for controlling phasing of advancing substrates in absorbent article converting lines
Aromatic amine derivative, organic electroluminescent element employing the same, and process for producing aromatic amine derivative
Optical packet signal transmission device and WDM optical communication network
Error detection and recovery tool for logical volume management in a data storage system
  Randomly Featured Patents
Intake control system for internal combustion engine
Array substrate for liquid crystal display substrate having high aperture ratio and method for fabricating the same
MLS gasket with wire ring stopper
Process for producing simvastatin
Synchronous semiconductor memory device allowing easy and fast test
Method and system for managing a plurality of I/O interfaces with an array of multicore processor resources in a semiconductor chip
Speed wrench and hand grip combination
Method and system for influencing the traffic flow within a route section
Vessel for safe handling of substances
Dispenser pump head for controlling misdirection